Dependence of Hydrogen Peroxide Formation in Rat Liver Microsomes on the Molecular Structure of Cytochrome P-450 Substrates: a Study with Barbiturates and Beta-adrenoceptor Antagonists

Overview

Journal Eur J Drug Metab Pharmacokinet

Date 1989 Apr 1

PMID 2574109

Authors

A Bast

P A Goossens

Affiliations

Soon will be listed here.

Abstract

In the present study, the molecular structure of xenobiotics has been successfully linked to their effect on the oxidase activity of cytochrome P-450, determined as microsomal hydrogen peroxide formation. A homologous series of 5-alkyl-5-ethyl barbiturates and a heterologous series of beta-adrenoceptor antagonists was used. The logarithm of the rate of microsomal hydrogen peroxide formation could be correlated with the logarithm of the apparent partition (n-octanol/buffer) coefficient for the barbiturate derivatives according to a parabolic function. The statistics of the correlation improved considerably by applying a bilinear model in order to fit the data. This probably indicates that both transport of the substrate to cytochrome P-450 and interaction with hydrophobic substrate binding sites of cytochrome P-450 are involved in the modulating effect of substrates on the oxidase function of cytochrome P-450. With the series of beta-adrenoceptor antagonists no clear-cut structure activity relationship with regard to the oxidase activity was apparent at first sight. However, when the inhibitory effect of the beta-antagonists on the 'cytochrome P-450 metabolic intermediate (MI) complex' formation that occurs during the microsomal biotransformation of 33 microM tofenacine was studied a relationship with the lipophilicity could be demonstrated. It is known that MI complex formation occurs with specific subforms of cytochrome P-450. By using this inhibitory activity of the beta-adrenoceptor antagonists, the interaction of the compounds becomes restricted to these specific subforms of cytochrome P-450. In both the oxidase activity as well as the MI complex formation phenobarbital induced cytochrome P-450 is involved.(ABSTRACT TRUNCATED AT 250 WORDS)

References

EKSTROM G, Ingelman-Sundberg M . Mechanisms of lipid peroxidation dependent upon cytochrome P-450 LM2. Eur J Biochem. 1986; 158(1):195-201. DOI: 10.1111/j.1432-1033.1986.tb09738.x. View

Hildebrandt A, Heinemeyer G, Roots I . Stoichiometric cooperation of NADPH and hexobarbital in hepatic microsomes during the catalysis of hydrogen peroxide formation. Arch Biochem Biophys. 1982; 216(2):455-65. DOI: 10.1016/0003-9861(82)90234-x. View

KUTHAN H, Ullrich V . Oxidase and oxygenase function of the microsomal cytochrome P450 monooxygenase system. Eur J Biochem. 1982; 126(3):583-8. DOI: 10.1111/j.1432-1033.1982.tb06820.x. View

Heinemeyer G, Nigam S, Hildebrandt A . Hexobarbital-binding, hydroxylation and hexobarbital-dependent hydrogen peroxide production in hepatic microsomes of guinea pig, rat and rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1980; 314(2):201-10. DOI: 10.1007/BF00504539. View

Bast A, van Kemenade F, Noordhoek J . Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat. Res Commun Chem Pathol Pharmacol. 1983; 40(3):391-403. View

Hildebrandt A, Roots I, Tjoe M, Heinemeyer G . Hydrogen peroxide in hepatic microsomes. Methods Enzymol. 1978; 52:342-50. DOI: 10.1016/s0076-6879(78)52037-5. View

GILLETTE J, Brodie B, La Du B . The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. J Pharmacol Exp Ther. 1957; 119(4):532-40. View

Bast A, Kroes B . Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers. Xenobiotica. 1984; 14(5):399-408. DOI: 10.3109/00498258409151428. View

Bast A, Brenninkmeijer J, Noordhoek J . Cytochrome P450 oxidase activity and its role in NADPH dependent lipid peroxidation. FEBS Lett. 1983; 151(2):185-8. DOI: 10.1016/0014-5793(83)80065-9. View

10.

Moldeus P, Orrenius S . On the mechanisms of glutathione depletion in hepatocytes exposed to morphine and ethylmorphine. Toxicology. 1986; 42(1):13-21. DOI: 10.1016/0300-483x(86)90088-0. View

11.

Gonder J, Proctor R, Will J . Genetic differences in oxygen toxicity are correlated with cytochrome P-450 inducibility. Proc Natl Acad Sci U S A. 1985; 82(18):6315-9. PMC: 391044. DOI: 10.1073/pnas.82.18.6315. View

12.

Bast A, Noordhoek J . Calculation of competitive inhibition of substrate binding to cytochrome P-450 illustrated by the interaction of d,l-propranolol with d,l-hexobarbital. Biochem Pharmacol. 2010; 29(5):747-51. DOI: 10.1016/0006-2952(80)90552-3. View

13.

Kumaki K, Nebert D . Spectral evidence for weak ligand in sixth position of hepatic microsomal cytochrome P-450 low spin ferric iron in vivo. Pharmacology. 1978; 17(5):262-79. DOI: 10.1159/000136865. View

14.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

15.

Rossing D, Kahl R, Hildebrandt A . Effect of synthetic antioxidants on hydrogen peroxide formation, oxyferro cytochrome P-450 concentration and oxygen consumption in liver microsomes. Toxicology. 1985; 34(1):67-77. DOI: 10.1016/0300-483x(85)90079-4. View

16.

Nash T . The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J. 1953; 55(3):416-21. PMC: 1269292. DOI: 10.1042/bj0550416. View

17.

Hildebraunt A, Roots I . Reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent formation and breakdown of hydrogen peroxide during mixed function oxidation reactions in liver microsomes. Arch Biochem Biophys. 1975; 171(2):385-97. DOI: 10.1016/0003-9861(75)90047-8. View

18.

Yih T, van Rossum J . K5 values of some homologous series of barbiturates and the relationship with the lipophilicity and metabolic clearance. Biochem Pharmacol. 1977; 26(22):2117-20. DOI: 10.1016/0006-2952(77)90261-1. View

19.

Bast A, Noordhoek J . Spectral interaction of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the rat. Biochem Pharmacol. 1982; 31(17):2745-53. DOI: 10.1016/0006-2952(82)90128-9. View